Cargando…

Universal drug-susceptibility testing of first-line drugs to preserve their efficacy: An essential strategy to defeat tuberculosis

Detalles Bibliográficos
Autor principal:	Dev Bhattarai, Madhur
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10475499/ https://www.ncbi.nlm.nih.gov/pubmed/37671085 http://dx.doi.org/10.1016/j.jctube.2023.100394

Ejemplares similares

Fluoroquinolone susceptibility in first-line drug-susceptible M. tuberculosis isolates in Lima, Peru
por: Schwalb, Alvaro, et al.
Publicado: (2021)

Optimal Sampling Strategies for Therapeutic Drug Monitoring of First-Line Tuberculosis Drugs in Patients with Tuberculosis
por: Saktiawati, Antonia Morita I., et al.
Publicado: (2019)

First Susceptibility Testing of Mycobacterium tuberculosis for Second-line Anti-tuberculosis Drugs in Ghana
por: Kato, Tomoko, et al.
Publicado: (2014)

Clinical Validation of the QMAC-DST System for Testing the Drug Susceptibility of Mycobacterium tuberculosis to First- and Second-Line Drugs
por: Lee, Sangyeop, et al.
Publicado: (2019)

The Exploitation of Liposomes in the Inhibition of Autophagy to Defeat Drug Resistance
por: Condello, Maria, et al.
Publicado: (2020)

Comparative evaluation of the Nitrate Reductase Assay and the Resazurin Microtitre Assay for drug susceptibility testing of Mycobacterium tuberculosis against first line anti-tuberculosis drugs
por: Sanchotene, Karine O., et al.
Publicado: (2008)

Resistance to First-Line Anti-TB Drugs Is Associated with Reduced Nitric Oxide Susceptibility in Mycobacterium tuberculosis
por: Idh, Jonna, et al.
Publicado: (2012)

Evaluation of BACTEC MGIT 960 System for Testing Susceptibility of Mycobacterium tuberculosis to First-Line Drugs in China
por: Zhao, Ping, et al.
Publicado: (2014)

Effectiveness and Pharmacokinetic Exposures of First-Line Drugs Used to Treat Drug-Susceptible Tuberculosis in Children: A Systematic Review and Meta-Analysis
por: Solans, Belén P, et al.
Publicado: (2023)

Performance of WHO-Endorsed Rapid Tests for Detection of Susceptibility to First-Line Drugs in Patients with Pulmonary Tuberculosis in Bangladesh
por: Rahman, S. M. Mazidur, et al.
Publicado: (2022)

Evaluation of Xpert(®) MTB/XDR test for susceptibility testing of Mycobacterium tuberculosis to first and second-line drugs in Uganda
por: Katamba, Achilles, et al.
Publicado: (2023)

Evaluation of Xpert MTB/XDR test for susceptibility testing of Mycobacterium tuberculosis to first and second-line drugs in Uganda
por: Katamba, Achilles, et al.
Publicado: (2023)

Intrapulmonary Pharmacokinetics of First-line Anti-tuberculosis Drugs in Malawian Patients With Tuberculosis
por: McCallum, Andrew D, et al.
Publicado: (2020)

DNA Sequencing Predicts 1st-Line Tuberculosis Drug Susceptibility Profiles
Publicado: (2018)

Defeat
por: Niburski, Kacper
Publicado: (2023)

Second-line anti-tuberculosis drug resistance testing in Ghana identifies the first extensively drug-resistant tuberculosis case
por: Osei-Wusu, Stephen, et al.
Publicado: (2018)

Impact of universal drug susceptibility testing and effective management of multidrug-resistant tuberculosis in Taiwan
por: Lee, Pin-Hui, et al.
Publicado: (2019)

Defeating Crypsis: Detection and Learning of Camouflage Strategies
por: Troscianko, Jolyon, et al.
Publicado: (2013)

Treatment of Drug Susceptible Pulmonary Tuberculosis
por: Shin, Hong-Joon, et al.
Publicado: (2015)

Drivers and Trajectories of Resistance to New First-Line Drug Regimens for Tuberculosis
por: Shrestha, Sourya, et al.
Publicado: (2014)

Evaluation of MGIT 960 System for the Second-Line Drugs Susceptibility Testing of Mycobacterium tuberculosis
por: Kim, Hyejin, et al.
Publicado: (2013)

Antimicrobial Susceptibility Testing of Mycobacterium Tuberculosis Complex for First and Second Line Drugs by Broth Dilution in a Microtiter Plate Format
por: Hall, Leslie, et al.
Publicado: (2011)

Resistance to Second-Line Antituberculosis Drugs and Delay in Drug Susceptibility Testing among Multidrug-Resistant Tuberculosis Patients in Shanghai
por: Chen, Yong, et al.
Publicado: (2016)

Pattern of drug resistance of Mycobacterium tuberculosis clinical isolates to first-line antituberculosis drugs in pulmonary cases
por: Kalo, Deepika, et al.
Publicado: (2015)

High occurrence of simultaneous multiple-drug hypersensitivity syndrome induced by first-line anti-tuberculosis drugs()
por: Sim, Da Woon, et al.
Publicado: (2021)

The Mycobacterium tuberculosisUganda II family and resistance to first-line anti-tuberculosis drugs in Uganda
por: Ezati, Nicholas, et al.
Publicado: (2014)

ADVERSE EVENTS TO FIRST LINE ANTI-TUBERCULOSIS DRUGS IN PATIENTS CO-INFECTED WITH HIV AND TUBERCULOSIS
por: Michael, O.S., et al.
Publicado: (2016)

First and Second-Line Anti-Tuberculosis Drug-Resistance Patterns in Pulmonary Tuberculosis Patients in Zambia
por: Monde, Ngula, et al.
Publicado: (2023)

Mycobacterium tuberculosis Genotypes Determined by Spoligotyping to Be Circulating in Colombia between 1999 and 2012 and Their Possible Associations with Transmission and Susceptibility to First-Line Drugs
por: Puerto, Gloria, et al.
Publicado: (2015)

Trends of Mycobacterium bovis Isolation and First-Line Anti-tuberculosis Drug Susceptibility Profile: A Fifteen-Year Laboratory-Based Surveillance
por: Bobadilla-del Valle, Miriam, et al.
Publicado: (2015)

Clinical Whole-Genome Sequencing Assay for Rapid Mycobacterium tuberculosis Complex First-Line Drug Susceptibility Testing and Phylogenetic Relatedness Analysis
por: Shaw, Bennett, et al.
Publicado: (2023)

Minimal inhibitory concentrations of first-line drugs of multidrug-resistant tuberculosis isolates
por: Schönfeld, Nicolas, et al.
Publicado: (2012)

Food significantly reduces plasma concentrations of first-line anti-tuberculosis drugs
por: Kumar, Agibothu Kupparam Hemanth, et al.
Publicado: (2017)

Determinants of serum concentration of first-line anti-tuberculosis drugs from China
por: Lei, Qian, et al.
Publicado: (2019)

Adolescent but not adult-born neurons are critical for susceptibility to chronic social defeat
por: Kirshenbaum, Greer S., et al.
Publicado: (2014)

Immune to defeat
por: Reese, Michael L
Publicado: (2013)

The Defeat of the Bill
Publicado: (1894)

Defeat Such Legislation
Publicado: (1901)

Comparison of line probe assay to BACTEC MGIT 960 system for susceptibility testing of first and second-line anti-tuberculosis drugs in a referral laboratory in South Africa
por: Maningi, Nontuthuko E., et al.
Publicado: (2017)

PknB remains an essential and a conserved target for drug development in susceptible and MDR strains of M. Tuberculosis
por: Gupta, Anamika, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_svb7t8fdb7sikaua296vps8cf0